Recently added articles from Cancer Weekly:
Experts issue call to reconsider screening for breast cancer and prostate cancer.
Nov 17, 2009 ... Twenty years of screening for breast and prostate cancer - the most diagnosed cancer for women and men - have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center ...
22nd Century Corrects Misinformation in News Article.
Nov 17, 2009 ... 22nd Century Limited, LLC ("22nd Century") announced that it is correcting some inaccuracies that appeared in a Minnesota Daily article entitled, Researcher upset by tobacco company's actions; University Researcher was not aware company used her research in their press release (see also ...
ARIAD's AP24534 Featured in Cancer Cell Publication as a Potential First-in-Class Pan BCR-ABL Inhibitor.
Nov 17, 2009 ... ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) announced that the scientific journal, Cancer Cell, has published a comprehensive paper describing the design and preclinical characterization of AP24534, ARIAD's investigational, multi-targeted kinase inhibitor. The paper, "AP24534, a Pan-BCR-ABL ...
BSD Medical Reports Hyperthermia Therapy Contributes to Improved Survival Rate for Bladder Cancer Patients.
Nov 17, 2009 ... BSD Medical Corporation (NASDAQ:BSDM) announced that published study results demonstrated improvement in overall survival, tumor response rates, and local tumor control from the addition of hyperthermia therapy, delivered using the BSD-2000 Hyperthermia System, to the standard treatment ...
Beating Cancer: a Blueprint for Survival.
Nov 17, 2009 ... In his debut memoir, "No Expiration Dates: A Cancer Patient's Strategies for Survival" (published by iUniverse), Leon Weisman recounts his unique and inspirational battle with lung cancer while also offering practical advice about the emotional and social changes that a cancer diagnosis ...